MedPath

Turmeric as an additive agent to treat Fibrosis of cheeks

Phase 4
Completed
Conditions
Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissueHealth Condition 2: null- Oral Submucous Fibrosis
Registration Number
CTRI/2015/07/006001
Lead Sponsor
Dr Nilima Sharma
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
41
Inclusion Criteria

Patients of either sex above 20 years of age.

A positive history of chewing arecanut or one of its commercial preparations.

Diagnosis of OSMF was made on the basis of natural history and characteristic clinical features which included the presence of burning sensation in the mouth, intolerance to spicy food, blanching and loss of suppleness of oral mucosa, presence of palpable fibrous bands and decreased mouth opening.

Exclusion Criteria

Patients with chronic illnesses and systemic diseases(diabetes, hypertension, liver disorders, kidney disorders, autoimmune disorders), other mucosal lesions.

Pregnant and lactating women.

Patients with a known allergy or contraindication to the study drugs.

Malignancy

Temporomandibular joint arthrosis , Fracture mandible ramus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacy of curcumin as an antioxidant adjuvant to corticosteroid injections in the management of oral submucous fibrosis.Timepoint: Every month
Secondary Outcome Measures
NameTimeMethod
1.Resumption of normal eating, chewing and speech. <br/ ><br>2.Change or improvement in maximal jaw opening, measuredas the interincisal distance. <br/ ><br>3.Reduction in fibrosis evaluated by pre and post treatment ultrasonography. <br/ ><br>4.Change in severity of oral/mucosal burning pain using Visual Analogue Scale validated pain scale. <br/ ><br>Timepoint: every 4 days for 3 months
© Copyright 2025. All Rights Reserved by MedPath